Home
About Us
Leadership
News
Technology
- Overview
- Publications
Pipeline
Contact Us

Andrew Summerfield

N8 Medical > Articles by: Andrew Summerfield

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant

July 5, 2022 7:17 pmJuly 5, 2022

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Email address:

Leave this field empty if you're human:

Recent Posts

N8 Medical and USAMRIID Enter CRADA to Test CSA Compounds Against Anthrax and other Biodefense Pathogens
FDA grants QIDP Designation For Kinnear’s CSA-131 drug for Life-threatening Pseudomonas Bacterial Infections in CF
NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws
N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant
N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes

N8 Medical, LLC

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.

About Us
Leadership
News
Technology
Pipeline
Contact Us

© 2019-2023 N8 Medical, LLC. All Rights Reserved. Privacy Policy

Menu

Home
About Us
Leadership
News
Technology
- Overview
- Publications
Pipeline
Contact Us